Search results
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 2 days agoSanofi plans to invest €1bn in Vitry-sur-Seine...biologics currently in development, targeting...
Temedica Expands Its Advisory Board With Former Gematik CEO Markus Leyck Dieken
NewMediaWire via Yahoo Finance· 38 minutes agoDr. med. Markus Leyck Dieken, former CEO of Gematik, joins the Advisory Board of Temedica. Dr. Leyck...
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Pharmaceutical Technology via Yahoo Finance· 1 day agoCircRNA is still in very early days of development, but it is expected to trialled in vaccines,...
Babies born by C-section need two doses of measles vaccine to produce antibodies
UPI· 2 days agoA single measles jab is up to 2.6 times more likely to be completely ineffective in C-section...
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 9 hours agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....
Cancer breakthrough as doctor with disease most die of in a year now cured
Daily Express· 1 day agoAn esteemed doctor has defied the odds by surviving an aggressive form of cancer following...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 3 days agoThe biotech is also advancing other programs to late-stage studies, including vaccines against the...
Too many Australians aren't getting a flu vaccine—why, and what can we do about it?
Medical Xpress· 3 days agoLooking back over recent years, for kids aged 6 months to 5 years, we saw a peak in flu vaccine...
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks via Yahoo Finance· 6 hours agoHere we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK),...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 10 hours agoAnimal health and vaccine products are core growth drivers. Merck boasts a strong cancer pipeline,...